...
首页> 外文期刊>Biopharmaceutics and Drug Disposition >Self-emulsifying drug delivery system of (R)-alpha-lipoic acid to improve its stability and oral absorption
【24h】

Self-emulsifying drug delivery system of (R)-alpha-lipoic acid to improve its stability and oral absorption

机译:(R) - 硫辛酸的自乳化药物递送系统,提高其稳定性和口服吸收

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

The present study was designed to develop a self-emulsifying drug delivery system (SEDDS) of (R)-alpha-lipoic acid (RLA) to improve the physicochemical and nutraceutical properties of RLA. RLA/SEDDS was prepared using medium-chain triglycerides, Tween 80, and polyethylene glycol 400 as oil, surfactant, and co-surfactant, respectively. The preferable composition of SEDDS was selected according to a pseudo-ternary phase diagram for improved emulsification properties, and its physicochemical and pharmacokinetic properties were evaluated. RLA/SEDDS showed the immediate formation of fine micelles with a mean droplet size of approximately 260 nm when introduced into aqueous media. In simulated gastric fluid, this system could significantly improve the dissolution behavior of RLA and prevent the degradation of RLA, possibly due to the encapsulation of RLA into the emulsion structure. Following the oral administration of RLA/SEDDS (10 mg RLA/kg) in rats, systemic exposure to RLA and dihydrolipoic acid (DHLA), a reduced form of RLA, increased by 7- and 3-fold, respectively. The improved dissolution and gastric stability of RLA could contribute to enhancing systemic exposure to RLA and DHLA after oral administration. From these findings, RLA/SEDDS might be an efficacious dosage option for improving the oral bioavailability as well as nutraceutical properties of RLA.
机译:本研究旨在开发一种自乳化药物递送系统(R) - 硫辛酸(RLA),以改善RLA的物理化学和营养化学性质。使用中链甘油三酯,吐温80和聚乙二醇400分别作为油,表面活性剂和共表面活性剂制备RLA / SEDDS。根据伪三元相图选择优选的静态组合物,用于改善乳化性能,并评估其物理化学和药代动力学性质。 RLA / SEDDS在引入水性介质时显示出直接形成细胶束的细胶束,其平均液滴尺寸约为260nm。在模拟胃液中,该系统可以显着改善RLA的溶解行为,并防止RLA的降解,可能是由于RLA进入乳液结构的封装。在大鼠中口服RLA / SEDDS(10mg RLA / kg)后,全身暴露于RLA和二氢硅酸(DHLA),降低的RLA形式,分别增加7-和3倍。 RLA的改善溶解和胃稳定性可有助于在口服给药后提高全身暴露于RLA和DHLA。从这些发现中,RLA / SEDDS可能是一种有效的剂量选择,用于改善口腔生物利用度以及RLA的营养性质。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号